Sustainability Investors Products Research & Development Company Contact
Sustainability
ESG Environment Social
Investors
Reasons to invest Share information News Reports Corporate governance Stock exchange notices
Products
Salmon protein hydrolysate Salmon oil Calcium bone powder Collagen peptides European webshops
Research & Development
Our research All research programs Studies Clinical Trial Unit
Company
About us Our technology Operations Management Board of directors Awards
Contact
Sales Investor relations Factories Management
Type and search

All notices

Hofseth BioCare - Giving CMA mandate to establish operational lease agreement

27.02.2013

Hofseth Biocare - ProGO a superior source to improve muscle recovery -INAF

21.02.2013

Hofseth BioCare - Promising results from production adjustments

12.02.2013

Hofseth BioCare - CEO Sjur Jenssen transfers 6,000 shares

07.02.2013

Hofseth BioCare - Changes in management

29.01.2013

Hofseth BioCare takes possession of the spray dryer facilities at Berkåk

21.01.2013

Mandatory notification of trade in Hofseth BioCare ASA (HBC)

11.01.2013

Hofseth BioCare - Non-novel food status for SPH in EU

02.11.2012

Hofseth Biocare - Issues 400,000 new shares

01.11.2012

HBC - Third quarter 2012 results

31.10.2012

Previous
23 24 25
26
27 28 29
...
30
Next
Sustainability
ESG Environment Social
Investors
Reasons to invest Share information News Reports Corporate governance Stock exchange notices
Products
Salmon protein hydrolysate Salmon oil Calcium bone powder Collagen peptides European webshops
Research & Development
Our research All research programs Studies Clinical Trial Unit
Company
About us Our technology Operations Management Board of directors Awards
Contact
Sales Investor relations Factories Management

Copyright 2021 Hofseth BioCare ASA
Privacy cookies